Neoadjuvantes Nivolumab in Kombination mit platinbasierter Chemotherapie bei operablem LungenkrebsNeoadjuvant nivolumab in combination with platinum-based chemotherapy for operable lung cancer

被引：0
|
作者：
Khosro Hekmat
Christiane J. Bruns
机构：
[1] Universität zu Köln,Klinik und Poliklinik für Herz
[2] Universität zu Köln, und Thoraxchirurgie
来源：
Die Chirurgie | 2023年 / 94卷 / 1期
关键词：
D O I：
10.1007/s00104-022-01778-6
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：77 / 78
页数：1
相关论文
共 50 条
  • [41] Second-line docetaxel and gemcitabine combination chemotherapy in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy - A phase II trial
    Tas, F
    Demir, C
    Camlica, H
    Ustuner, Z
    Topuz, E
    MEDICAL ONCOLOGY, 2004, 21 (03) : 233 - 240
  • [42] Combination immune checkpoint inhibitors with platinum-based chemotherapy in advanced non-small cell lung cancer: what's known and what's next
    Jiang, Tao
    Zhou, Caicun
    Hu, Jie
    Song, Yuanlin
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 : S447 - S450
  • [43] PLATINUM-BASED COMBINATION CHEMOTHERAPY IN ADVANCED NON-SMALL-CELL LUNG-CANCER - A RANDOMIZED PHASE-II TRIAL OF THE CANCER AND LEUKEMIA GROUP-B
    GREEN, MR
    KRAMAR, A
    SCHILSKY, R
    STOOPLER, M
    ZIMMER, B
    RICHARDS, F
    SKARIN, A
    ANDERSON, JR
    MEDICAL AND PEDIATRIC ONCOLOGY, 1990, 18 (03): : 197 - 202
  • [44] A phase I study of nivolumab (anti-PD-1; BMS-936558, ONO-4538) plus platinum-based doublet chemotherapy (PT-doublet) in chemotherapy-naive non-small cell lung cancer (NSCLC) patients (pts)
    Rizvi, Naiyer A.
    Antonia, Scott J.
    Chow, Laura Quan Man
    Brahmer, Julie R.
    Juergens, Rosalyn A.
    Borghaei, Hossein
    Shepherd, Frances A.
    Laurie, Scott Andrew
    Gerber, David E.
    Goldman, Jonathan Wade
    Shen, Yun
    Harbison, Christopher
    Alaparthy, Suresh
    Chen, Allen C.
    Gettinger, Scott N.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [45] Comparison of platinum combination chemotherapy plus pembrolizumab versus platinum combination chemotherapy plus nivolumab-ipilimumab for treatment-naive advanced non-small-cell lung cancer in Japan (JCOG2007): an open-label, multicentre, randomised, phase 3 trial
    Shiraishi, Yoshimasa
    Nomura, Shogo
    Sugawara, Shunichi
    Horinouchi, Hidehito
    Yoneshima, Yasuto
    Hayashi, Hidetoshi
    Azuma, Koichi
    Hara, Satoshi
    Niho, Seiji
    Morita, Ryo
    Yamaguchi, Masafumi
    Yokoyama, Toshihide
    Yoh, Kiyotaka
    Kurata, Takayasu
    Okamoto, Hiroaki
    Okamoto, Masaki
    Kijima, Takashi
    Kasahara, Kazuo
    Fujiwara, Yutaka
    Murakami, Shuji
    Kanda, Shintaro
    Akamatsu, Hiroaki
    Takemoto, Shinnosuke
    Kaneda, Hiroyasu
    Kozuki, Toshiyuki
    Ando, Masahiko
    Sekino, Yuta
    Fukuda, Haruhiko
    Ohe, Yuichiro
    Okamoto, Isamu
    LANCET RESPIRATORY MEDICINE, 2024, 12 (11): : 877 - 887
  • [46] A Multicenter, Randomized Phase III Study Comparing Platinum Combination Chemotherapy Plus Pembrolizumab With Platinum Combination Chemotherapy Plus Nivolumab and Ipilimumab for Treatment-Naive Advanced Non-Small Cell Lung Cancer Without Driver Gene Alterations: JCOG2007 (NIPPON Study)
    Shiraishi, Yoshimasa
    Hakozaki, Taiki
    Nomura, Shogo
    Kataoka, Tomoko
    Tanaka, Kentaro
    Miura, Satoru
    Sekino, Yuta
    Ando, Masahiko
    Horinouchi, Hidehito
    Ohe, Yuichiro
    Okamoto, Isamu
    CLINICAL LUNG CANCER, 2022, 23 (04) : E285 - E288
  • [47] A Phase II "open", non-randomized multicenter Study to evaluate the Efficacy and Safety of Nivolumab plus Ipilimumab in Patients with Cancer of unknown Primary Origin and Progression or Recurrence after platinum-based Chemotherapy (CheCUP)
    Pouyiourou, M.
    Kraft, B.
    Wohlfromm, T.
    Stahl, M.
    Kubuschok, B.
    Loeffler, H.
    Hacker, U.
    Huebner, G.
    Westphalen, C. B.
    Bitzer, M.
    Ernst, T.
    Schuett, P.
    Hielscher, T.
    Delorme, S.
    Stenzinger, A.
    Bochtler, T.
    Kraemer, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 163 - 163
  • [48] Long-term survival follow-up of atezolizumab in combination with platinum-based doublet chemotherapy in patients with advanced non-small-cell lung cancer
    Liu, Stephen V.
    Camidge, D. Ross
    Gettinger, Scott N.
    Giaccone, Giuseppe
    Heist, Rebecca S.
    Hodi, F. Stephen
    Ready, Neal E.
    Zhang, Wei
    Wallin, Jeffrey
    Funke, Roel
    Waterkamp, Daniel
    Foster, Paul
    Iizuka, Koho
    Powderly, John
    EUROPEAN JOURNAL OF CANCER, 2018, 101 : 114 - 122
  • [49] Epidermal growth factor receptor expression analysis in chemotherapy-naive patients with advanced non-small-cell lung cancer treated with gefitinib or placebo in combination with platinum-based chemotherapy
    Giuseppe Giaccone
    Renee B. Iacona
    Abderrahim Fandi
    Mette Janas
    Judith S. Ochs
    Roy S. Herbst
    David H. Johnson
    Journal of Cancer Research and Clinical Oncology, 2009, 135 : 467 - 476
  • [50] A phase 1b study of ensartinib in combination with platinum-based chemotherapy and bevacizumab in ALK-positive non-small cell lung cancer (NSCLC)
    Concannon, Kyle
    Selvaggi, Giovanni
    Zhou, Joey
    Elamin, Yasir Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345